SHE:300573 Revenue

Shenyang Xingqi Pharmaceutical had revenue of 536.14M CNY in the quarter ending March 31, 2025, with 53.24% growth. This brings the company's revenue in the last twelve months to 2.13B, up 39.11% year-over-year. In the year 2024, Shenyang Xingqi Pharmaceutical had annual revenue of 1.94B with 32.42% growth.

Revenue (ttm)

2.13B

Revenue Growth

+39.11%

P/S Ratio

6.44

Revenue / Employee

877.85K

Employees

2,426

Market Cap

13.72B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.94B	475.82M	32.42%
Dec 31, 2023	1.47B	217.71M	17.42%
Jan 1, 2023	1.25B	221.94M	21.59%
Jan 1, 2022	1.03B	339.23M	49.26%
Dec 31, 2020	688.68M	146.25M	26.96%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings